Skip to content
  1. Home/
  2. Latest news/
  3. Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions
David Westin and Johnson & Johnson Chairman and CEO Alex Gorsky Sat Down for An Interview for Bloomberg Big Decisions
David Westin (left) and Johnson & Johnson Chairman and CEO Alex Gorsky sat down for an interview for Bloomberg Big Decisions A.E. Fletcher Photography

Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions

See what Alex Gorsky had to say about his goal to help change the trajectory of health for humanity—and how he believes the U.S. healthcare system must change for the better.

David Westin (left) and Johnson & Johnson Chairman and CEO Alex Gorsky sat down for an interview for Bloomberg Big Decisions A.E. Fletcher Photography

What do serving in the military and overseeing the world’s largest healthcare company have in common?

Both require that you earn the right to lead and fulfill your duty to those you serve—whether that’s your country or the patients, consumers, employees and stockholders you represent, says Johnson & Johnson Chairman and CEO Alex Gorsky, who served as a captain in the U.S. Army.

That’s just one of the insights he revealed last week during an interview with David Westin of Bloomberg Big Decisions that was filmed at the company’s new museum, where he answered tough questions on transparency in drug pricing and affordable healthcare—and explained why his biggest legacy will be to live up to Johnson & Johnson’s historic company code of conduct, the Credo.

Watch the full interview here on Bloomberg.com.


More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.